Autologous Human Adipose-Derived Mesenchymal Stem Cells in Alzheimer's Disease

Summary

This is a single patient emergency expanded access clinical study to assess the safety of administering autologous AdMSCs to an incurable Alzheimer disease patient. The study subject will be evaluated for disease-associated severity according to symptoms, cognitive function, memory, and quality of life.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications